Roche Pharma (Schweiz) AG - Erivedge, Kapseln | | 62497 | | 01 | | Erivedge | | Kapseln | | L01XJ01 | | Vismodegib | | 30.05.2013 | | |
| Composition | vismodegibum 150 mg, cellulosum microcristallinum, lactosum monohydricum 71.5 mg, natrii laurilsulfas, povidonum K 29-32, carboxymethylamylum natricum, talcum, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (nigrum), Drucktinte: lacca, E 172 (nigrum), excipiens pro capsula corresp. natrium 1.09 - 1.34 mg. | Packungsbestandteile | | Capsules | | | | | | Active Agent | Dose |
---|
Vismodegibum | 150 mg |
| BAG: Active Agent | Dose |
---|
Vismodegibum | 150 mg |
| | Inactive agents | Dose | additional_information |
---|
(Nigrum) | | | (Rubrum) | | | Carboxymethylamylum Natricum | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | Gelatina | | Kapselhülle | Lacca | | Drucktinte | Lactose Monohydrate | 71.5 mg | | Magnesii Stearas | | | Natrii Laurilsulfas | | | Povidonum K | 29-32 | | Talcum | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
001 | 28 Capsule(s) | 4882.26 | 5317.00 | A | SL | No |
|
|